Clomid users may find IVF success with blood tests
Many women who are struggling with fertility issues use Clomid to change their bodies' hormone balance and induce ovulation.
Many women who are struggling with fertility issues use Clomid to change their bodies' hormone balance and induce ovulation. New information shows that these patients could benefit from a blood test to determine their levels of Anti-Mullerian hormone and in turn predict their chances of becoming pregnant through in vitro fertilization (IVF).
A study published in the March 2013 edition of the Journal of Clinical Endocrinology and Metabolism by researchers at Uppsala University found that, no matter their age, women with high levels of AMH were 2.5 times more likely to become pregnant and experience a live birth after IVF than women with lower AMH levels. This is the first study to show that, no matter the number of eggs retrieved for IVF, there is a direct connection between AMH and pregnancy and birth rates. Previous studies have established the connection between higher levels of AMH and the likelihood of several healthy eggs remaining.
Researchers advised that AMH tests could suggest an individualized treatment plan for each patient struggling with fertility. They concluded that more research must be done to analyze the costs and benefits of using AMH to determine ovarian reserve.